Skip to main content
. 2022 Jul 16;17(4):441–451. doi: 10.1007/s11523-022-00899-6

Fig. 1.

Fig. 1

Flowchart of included patients. mCRPC metastatic castration resistance prostate cancer, mHSPC metastatic hormone-sensitive prostate cancer, nmCRPC non-metastatic castration-resistant prostate cancer